Document is current
Any future updates will be listed below
-
Authors
Sengler, Claudia https://orcid.org/0000-0002-6703-0269
Klotsche, Jens
Pedersen, Malthe Jessen
Niewerth, Martina
Göldel, Julia
Windschall, Daniel
Haas, Johannes-Peter
Dressler, Frank
Trauzeddel, Ralf
Hospach, Anton
Weller-Heinemann, Frank
Lanzinger, Stefanie
Kamrath, Clemens
Holl, Reinhard W.
Warschburger, Petra
Minden, Kirsten
-
Funding
Funding for this research was provided by:
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
- License Information
-
More Information
Article History
Received: 14 January 2024
Accepted: 25 March 2024
First Online: 18 April 2024
Declarations
:
: The KICK-COVID study was approved by the ethics committee of the University of Potsdam (request number 62/2020) and conducted according the Declaration of Helsinki as well as the EU General Data Protection Regulation (GDPR). The NPRD was approved by the ethics committee of the Charité—Universitätsmedizin Berlin (EA1/044/07).Children and adolescents with rheumatic diseases are included in the study after informed consent of the parents (for children under 8 years of age) or the children and adolescents themselves.
: Not applicable.
: CS: none; NG: none; MJP: none; MN: none; JK: none; JG: none; DW: none; JPH: none; FD: speaker`s fees from Novartis and Pfizer; RT: none, AH: none; FWH: none, SL: none, CK: none; RWH: none, PW: none; KM: received honoraria from Amgen, Pfizer, Novartis and medac.
